MEDYSSEY Co.,Ltd (XKON:200580)

Verve Therapeutics Statistics

Total Valuation

XKON:200580 has a market cap or net worth of KRW 27.69 billion.

Market Cap	27.69B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:200580 has 3.48 million shares outstanding.

Current Share Class	3.48M
Shares Outstanding	3.48M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.09M

Valuation Ratios

The trailing PE ratio is 6.48.

PE Ratio	6.48
Forward PE	n/a
PS Ratio	2.61
PB Ratio	2.14
P/TBV Ratio	2.15
P/FCF Ratio	n/a
P/OCF Ratio	24.15
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.23.

Current Ratio	3.69
Quick Ratio	2.27
Debt / Equity	0.23
Debt / EBITDA	1.09
Debt / FCF	-11.86
Interest Coverage	22.33

Financial Efficiency

Return on equity (ROE) is 19.39% and return on invested capital (ROIC) is 9.79%.

Return on Equity (ROE)	19.39%
Return on Assets (ROA)	8.71%
Return on Invested Capital (ROIC)	9.79%
Return on Capital Employed (ROCE)	14.68%
Revenue Per Employee	132.49M
Profits Per Employee	24.73M
Employee Count	80
Asset Turnover	0.72
Inventory Turnover	1.10

Taxes

In the past 12 months, XKON:200580 has paid 190.13 million in taxes.

Income Tax	190.13M
Effective Tax Rate	8.77%

Stock Price Statistics

The stock price has decreased by -23.97% in the last 52 weeks. The beta is 0.17, so XKON:200580's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-23.97%
50-Day Moving Average	7,602.80
200-Day Moving Average	8,052.70
Relative Strength Index (RSI)	53.94
Average Volume (20 Days)	469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:200580 had revenue of KRW 10.60 billion and earned 1.98 billion in profits. Earnings per share was 1,229.00.

Revenue	10.60B
Gross Profit	5.71B
Operating Income	2.06B
Pretax Income	2.17B
Net Income	1.98B
EBITDA	2.76B
EBIT	2.06B
Earnings Per Share (EPS)	1,229.00

Balance Sheet

The company has 4.21 billion in cash and 3.02 billion in debt, giving a net cash position of 1.19 billion or 342.19 per share.

Cash & Cash Equivalents	4.21B
Total Debt	3.02B
Net Cash	1.19B
Net Cash Per Share	342.19
Equity (Book Value)	12.95B
Book Value Per Share	8,007.45
Working Capital	9.64B

Cash Flow

In the last 12 months, operating cash flow was 1.15 billion and capital expenditures -1.40 billion, giving a free cash flow of -254.34 million.

Operating Cash Flow	1.15B
Capital Expenditures	-1.40B
Free Cash Flow	-254.34M
FCF Per Share	-73.12

Margins

Gross margin is 53.91%, with operating and profit margins of 19.39% and 18.66%.

Gross Margin	53.91%
Operating Margin	19.39%
Pretax Margin	20.46%
Profit Margin	18.66%
EBITDA Margin	26.04%
EBIT Margin	19.39%
FCF Margin	n/a

Dividends & Yields

XKON:200580 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.15%
FCF Yield	-0.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:200580 has an Altman Z-Score of 2.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.34
Piotroski F-Score	3